Dr. Hucks is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
170 Manning Drive Cb
# 7236
Chapel Hill, NC 27599
Education & Training
- Children's Hospital of PhiladelphiaFellowship, Pediatric Hematology/Oncology, 2016 - 2017
- University of MichiganFellowship, Pediatric Hematology/Oncology, 2009 - 2012
- Wake Forest University Baptist Medical CenterResidency, Pediatrics, 2006 - 2009
- University of South Carolina School of MedicineClass of 2006
Certifications & Licensure
- NC State Medical License 2006 - 2025
- PA State Medical License 2016 - 2018
- MI State Medical License 2009 - 2015
- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Hematology-Oncology
Clinical Trials
- Biomarkers in Tumor Tissue Samples From Patients With Newly Diagnosed Neuroblastoma or Ganglioneuroblastoma Start of enrollment: 2000 Nov 06
- Risk-Based Classification System of Patients With Newly Diagnosed Acute Lymphoblastic Leukemia Start of enrollment: 2010 Aug 09
- Blood Sample Markers of Reproductive Hormones in Assessing Ovarian Reserve in Younger Patients With Newly Diagnosed Lymphomas Start of enrollment: 2013 Jun 17
- Join now to see all
Publications & Presentations
PubMed
- 3 citationsAnti-CD30 CAR T cells as consolidation after autologous haematopoietic stem-cell transplantation in patients with high-risk CD30lymphoma: a phase 1 study.Natalie S Grover, George Hucks, Marcie L Riches, Anastasia Ivanova, Dominic T Moore
The Lancet. Haematology. 2024-05-01 - Multiple lineage switches in KMT2A rearranged infant leukemia, responsive to combination therapy with CPX-351 and inotuzumab.Justin Sperlazza, Jonathan Galeotti, George Hucks, Thomas B Alexander
Pediatric Blood & Cancer. 2023-11-01 - 29 citationsPretherapy metabolic tumor volume associates with response to CD30 CAR T cells in Hodgkin lymphoma.Timothy J Voorhees, Beibo Zhao, Jorge Oldan, George E Hucks, Amir H. Khandani
Blood Advances. 2021-10-19
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: